Compare · DELL vs OMCL
DELL vs OMCL
Side-by-side comparison of Dell Technologies Inc. (DELL) and Omnicell Inc. (OMCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DELL and OMCL operate in Computer Manufacturing (Technology), so they compete in similar markets.
- DELL is the larger of the two at $256.87B, about 123.1x OMCL ($2.09B).
- Over the past year, DELL is up 207.5% and OMCL is up 63.3% - DELL leads by 144.1 points.
- DELL has been more active in the news (23 items in the past 4 weeks vs 6 for OMCL).
- DELL has more recent analyst coverage (25 ratings vs 24 for OMCL).
- Company
- Dell Technologies Inc.
- Omnicell Inc.
- Price
- $396.40+1.31%
- $45.80-2.53%
- Market cap
- $256.87B
- $2.09B
- 1M return
- -1.94%
- +14.67%
- 1Y return
- +207.45%
- +63.34%
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- 2001
- News (4w)
- 23
- 6
- Recent ratings
- 25
- 24
Dell Technologies Inc.
Dell Technologies Inc. designs, develops, manufactures, markets, sells, and supports Information technology solutions, products, and services worldwide. It operates through three segments: Infrastructure Solutions Group (ISG), Client Solutions Group (CSG), and VMware. The ISG segment provides traditional and next-generation storage solutions; and rack, blade, tower, and hyperscale servers. This segment also offers networking products and services that help its business customers to transform and modernize their infrastructure, mobilize and enrich end-user experiences, and accelerate business applications and processes; attached software and peripherals; and support and deployment, configuration, and extended warranty services. The CSG segment provides desktops, workstations, and notebooks; displays and projectors; attached and third-party software and peripherals, as well as support and deployment, configuration, and extended warranty services. The VMware segment supports and addresses various IT priorities of customers, including accelerating their cloud journey, migrating and modernizing their applications, empowering digital workspaces, transforming networking, and embracing intrinsic security. It enables its customers to digitally transform their operations as they ready their applications, infrastructure, and employees for constantly evolving business needs. This segment also offers cloud-native platform that makes software development and IT operations a strategic advantage for customers. The company also provides information security; cloud software and infrastructure-as-a-service solutions that enable customers to migrate, run, and manage mission-critical applications in cloud-based IT environments; cloud-based integration services; and financial services. The company was formerly known as Denali Holding Inc. and changed its name to Dell Technologies Inc. in August 2016. Dell Technologies Inc. was founded in 1984 and is headquartered in Round Rock, Texas.
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest DELL
- Director Slta V (Gp), L.L.C. disposed of 201,173 units of Class C Common Stock (SEC Form 4)
- Director Slta Iv (Gp), L.L.C. disposed of 201,173 units of Class C Common Stock (SEC Form 4)
- Director Silver Lake Technology Investors Iv, L.P. converted options into 1,332 units of Class C Common Stock and sold $604,114 worth of Class C Common Stock (1,332 units at $453.54) (SEC Form 4)
- Director Silver Lake Partners V De (Aiv), L.P. converted options into 48,990 units of Class C Common Stock and sold $15,814,436 worth of Class C Common Stock (34,869 units at $453.54) (SEC Form 4)
- Director Sl Spv-2, L.P. converted options into 88,164 units of Class C Common Stock and sold $26,981,925 worth of Class C Common Stock (59,492 units at $453.54) (SEC Form 4)
- Director Silver Lake Technology Investors V, L.P. converted options into 600 units of Class C Common Stock and sold $272,579 worth of Class C Common Stock (601 units at $453.54) (SEC Form 4)
- Director Silver Lake Partners Iv, L.P. converted options into 90,504 units of Class C Common Stock and sold $31,160,825 worth of Class C Common Stock (68,706 units at $453.54) (SEC Form 4)
- Director Sl Spv-2, L.P. converted options into 93,479 units of Class C Common Stock and sold $26,951,337 worth of Class C Common Stock (63,095 units at $427.15) (SEC Form 4)
- Director Silver Lake Technology Investors V, L.P. sold $271,229 worth of Class C Common Stock (635 units at $427.13) and converted options into 637 units of Class C Common Stock (SEC Form 4)
- Director Silver Lake Technology Investors Iv, L.P. converted options into 1,412 units of Class C Common Stock and sold $602,720 worth of Class C Common Stock (1,411 units at $427.16) (SEC Form 4)
Latest OMCL
- CHAIRMAN, CEO Lipps Randall A sold $470,000 worth of shares (10,000 units at $47.00) as part of a pre-agreed trading plan (SEC Form 4)
- Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
- SEC Form S-8 filed by Omnicell Inc.
- President & COO Njoku Nnamdi was granted 12,309 shares, increasing direct ownership by 8% to 167,094 units (SEC Form 4)
- Omnicell Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Nnamdi Njoku Appointed President of Omnicell
- Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
- Director Bousa Edward Peter was granted 4,603 shares, increasing direct ownership by 26% to 22,589 units (SEC Form 4)
- Director Scott Bruce E was granted 4,627 shares, increasing direct ownership by 20% to 27,600 units (SEC Form 4)
- Director Seim Robin Gene was granted 4,845 shares, increasing direct ownership by 10% to 52,198 units (SEC Form 4)